BillionToOne, Inc. is disrupting molecular diagnostics, leveraging proprietary smNGS technology for rapid growth and a $5.2B market cap. I rate BLLN stock as Buy. - BillionToOne, Inc. is disrupting molecular diagnostics, leveraging proprietary smNGS technology for rapid growth and a $5.2B market cap.
ProAmpac is recognized for consistently churning out new food packaging products and growing via a variety of acquisitions. That eye for M&A doesn't detract from ProAmpac's push for organic growth, though. The company uses material science to develop new…
SAN FRANCISCO, October 29, 2026--Edison Scientific announces agreement with Pfizer to accelerate research and development Oops, something went wrong U.S. markets close in 4h 53m Edison Scientific Announces Agreement with Pfizer to Accelerate Research and Development SAN FRANCISCO, October 29, 2026--(BUSINESS WIRE)--Edison Scientific announced…
Maria Maccecchini, PhD, CEO of Annovis, will join industry panel with pharma leaders and present company updates U.S. Biotech Day 2026 | November 16–17, 2026 | Philadelphia, PA Panel: "Bridging the Translational Gap: From Discovery Insights to Clinical Proof", November 16, 9:15–9:45 a.m. ET Company showcase: November…
Indian American tech entrepreneurs DJ Patil and Manohar Paluri in partnership with Kevin Weil and Solomon Reisberg, have launched Warp Sciences with $215 million to accelerate drug discovery in the United States. AI can design new molecules, but a design only…
The collaboration will focus on applying Lunit SCOPE IO to H&E-stained whole-slide pathology images to characterise tumour microenvironment features. "We are pleased to work with Lunit to explore how AI-powered pathology can help generate deeper, more scalable insights from…
Dr. Ashwini Zenooz will lead the Life Sciences and Healthcare sector, overseeing BIOVIA, MEDIDATA and ArisGlobal. Dassault Systèmes announced it has completed the acquisition of ArisGlobal and is now uniting its Life Sciences and Healthcare capabilities into a unified AI…
Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced a collaboration with Aceso Therapeutics, a biotech developing novel therapies for cystic fibrosis (CF), a rare genetic disease, to advance the development of ACT-101, an…
NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness, announced today it has joined the Industry Resource Partnership (IRP) Program of the California Institute for Regenerative Medicine (CIRM), a state agency. The…
Boost ROI by outsourcing preclinical testing to cut costs and timelines, while using AI, automation, in silico models and organ-on-chip platforms to improve accuracy. Dublin, Oct. 27, 2026 (GLOBE NEWSWIRE) -- "Preclinical Contract Research Organizations - Global Strategic Business Report" has been added to…
The money behind biotech: venture rounds and new startups, IPOs, acquisitions, licensing deals and the biotech stock market.
An article joins this feed when it matches these terms. Each one is also a search of its own.